US 9,872,910 B2Granted

Aqueous ophthalmic composition

AssigneeFUJIFILM Corporation

InventorsShirou Sonoke, Yasuyuki Izumi, Shigetomo Tsujihata

Life of this patent

Estimating the term…

Abstract

An aqueous ophthalmic composition includes a carbonic anhydrase inhibitor; at least one cellulose derivative selected from the group consisting of hydroxypropylmethyl cellulose acetate succinate and carboxymethylethyl cellulose; and water.

Claims7

Dependent claims

An aqueous ophthalmic composition comprising:

a carbonic anhydrase inhibitor;
a cellulose derivative comprising hydroxypropylmethyl cellulose acetate succinate;
another cellulose derivative comprising hydroxypropylmethyl cellulose;
and
water.

2 more elements

Dependencies are inferred from the claim text.

Facts

Application: 15/399,757Filed 6 Jan 2017 · continuation
Priority: JP 2014-14364111 Jul 2014
Published: US 2017/0112934 A127 Apr 2017
Granted: 23 Jan 2018
Term ends: Not estimatedThe source records don’t support an estimate.

Classification18 codes

A61K 47/32
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates: macromolecular compounds obtained by reactions only involving…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 9/08
Medicinal preparations characterised by special physical form: solutions
A61K 9/10
Medicinal preparations characterised by special physical form: dispersions; Emulsions

Family

PCT/JP2015/069963Parent of this continuation · filed 10 Jul 2015
US 2017/0112934 A1Pre-grant publication · published 27 Apr 2017
US 9,872,910 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results